Clinical Protocol 204503 - Cognitive Function & Mobility Pain Study

• Research type

  Research Study

• Full title

  Assessment of cognitive function and mobility in individuals with pain

• IRAS ID

  185251

• Contact name

  Judith Mackay

• Contact email

  jmackay@medinovaresearch.com

• Sponsor organisation

  GlaxoSmithKline Consumer Healthcare

• Eudract number

  2015-002330-42

• Duration of Study in the UK

  0 years, 3 months, 14 days

• Research summary

  Pain is a multidimensional, subjective experience, which can have an effect both physically and psychologically. Individuals with chronic pain often report deficits in their mobility and cognitive function is also thought to be affected. Whilst a vast amount of research has been conducted on individuals with chronic or disease specific pain there is very little known about the cognitive and mobility deficit experienced by individuals with everyday pain (pain treatable with Over-the-Counter OTC) medicine).
  The primary focus of this exploratory study will be to investigate the effects of everyday pain on cognition and mobility in otherwise healthy individuals. This study will also evaluate the relationship between specific types and intensity of everyday pain with cognitive function and mobility. Finally, the potential effect of an intervention with paracetamol or paracetamol with caffeine on cognitive function and mobility will be studied on an exploratory basis.

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  16/EM/0319

• Date of REC Opinion

  9 Aug 2016

• REC opinion

  Further Information Favourable Opinion